Literature DB >> 11016427

Lessons from BXSB and related mouse models.

S Izui1, N Ibnou-Zekri, L Fossati-Jimack, M Iwamoto.   

Abstract

The BXSB murine strain spontaneously develops an autoimmune syndrome with features of systemic lupus erythematosus (SLE) that affects males much earlier than females, due to the presence of an as yet unidentified mutant gene located on its Y chromosome, designated Yaa (Y-linked autoimmune acceleration). The Yaa gene by itself is unable to induce significant autoimmune responses in mice without an apparent SLE background, while it can induce and accelerate the development of an SLE in combination with autosomal susceptibility alleles present in lupus-prone mice. Although the genes encoded within or closely linked to the MHC locus play an important role in the development or protection of SLE, the MHC effect can be completely masked by the presence of the Yaa gene in mice highly predisposed to SLE. The role of the Yaa gene for the acceleration of SLE is apparently two-fold; it enhances overall autoimmune responses against autoantigens to which mice respond relatively weakly, and promotes Th 1 responses against autoantigens to which mice respond relatively well, leading to the production of more pathogenic autoantibodies, i.e., FcgammaR-fixing IgG2a and cryoglobulin IgG3 autoantibodies. Yaa+ - Yaa- double bone marrow chimera experiments revealed that the Yaa defect is expressed in B cells, but not in T cells, and that T cells from non-autoimmune mice are capable of providing help for autoimmune responses by collaborating Yaa+ B cells. We speculate that the Yaa defect may decrease the threshold for antigen receptor-dependent stimulation, leading to the triggering and excessive stimulation of autoreactive T and B cells.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11016427     DOI: 10.3109/08830180009055507

Source DB:  PubMed          Journal:  Int Rev Immunol        ISSN: 0883-0185            Impact factor:   5.311


  12 in total

1.  Evidence that the Y chromosome influences autoimmune disease in male and female mice.

Authors:  Cory Teuscher; Rajkumar Noubade; Karen Spach; Benjamin McElvany; Janice Y Bunn; Parley D Fillmore; James F Zachary; Elizabeth P Blankenhorn
Journal:  Proc Natl Acad Sci U S A       Date:  2006-05-15       Impact factor: 11.205

2.  Bacterial lipopolysaccharide both renders resistant mice susceptible to mercury-induced autoimmunity and exacerbates such autoimmunity in susceptible mice.

Authors:  M Abedi-Valugerdi; C Nilsson; A Zargari; F Gharibdoost; J W DePierre; M Hassan
Journal:  Clin Exp Immunol       Date:  2005-08       Impact factor: 4.330

3.  VISA is required for B cell expression of TLR7.

Authors:  Liang-Guo Xu; Lei Jin; Bi-Cheng Zhang; Linda J Akerlund; Hong-Bing Shu; John C Cambier
Journal:  J Immunol       Date:  2011-11-21       Impact factor: 5.422

4.  IL-21 is a double-edged sword in the systemic lupus erythematosus-like disease of BXSB.Yaa mice.

Authors:  Caroline G McPhee; Jason A Bubier; Thomas J Sproule; Giljun Park; Martin P Steinbuck; William H Schott; Gregory J Christianson; Herbert C Morse; Derry C Roopenian
Journal:  J Immunol       Date:  2013-09-27       Impact factor: 5.422

Review 5.  Molecular and cellular basis for pathogenicity of autoantibodies: lessons from murine monoclonal autoantibodies.

Authors:  Lucie Baudino; Samareh Azeredo da Silveira; Munehiro Nakata; Shozo Izui
Journal:  Springer Semin Immunopathol       Date:  2006-09-05

Review 6.  A genomic approach to human autoimmune diseases.

Authors:  Virginia Pascual; Damien Chaussabel; Jacques Banchereau
Journal:  Annu Rev Immunol       Date:  2010       Impact factor: 28.527

7.  Role of nucleic acid-sensing TLRs in diverse autoantibody specificities and anti-nuclear antibody-producing B cells.

Authors:  Yi Ting Koh; John C Scatizzi; Jennifer D Gahan; Brian R Lawson; Roberto Baccala; K Michael Pollard; Bruce A Beutler; Argyrios N Theofilopoulos; Dwight H Kono
Journal:  J Immunol       Date:  2013-04-15       Impact factor: 5.422

8.  MS2 VLP-based delivery of microRNA-146a inhibits autoantibody production in lupus-prone mice.

Authors:  Yang Pan; Tingting Jia; Yuan Zhang; Kuo Zhang; Rui Zhang; Jinming Li; Lunan Wang
Journal:  Int J Nanomedicine       Date:  2012-12-03

Review 9.  Interleukin-21: a new mediator of inflammation in systemic lupus erythematosus.

Authors:  Massimiliano Sarra; Giovanni Monteleone
Journal:  J Biomed Biotechnol       Date:  2010-06-28

10.  Blockade of B-cell-activating factor suppresses lupus-like syndrome in autoimmune BXSB mice.

Authors:  Hanlu Ding; Li Wang; Xiongfei Wu; Jun Yan; Yani He; Bing Ni; Wenda Gao; Xuemei Zhong
Journal:  J Cell Mol Med       Date:  2009-07-20       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.